A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder

S. A. Montgomery, A. McIntyre, M. Osterheider, P. Sarteschi, W. Zitterl, J. Zohar, M. Birkett, A. J. Wood

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences